Search Results - Judith E. Karp

Refine Results
  1. 1
    Minimal residual disease in acute myeloid leukaemia

    Minimal residual disease in acute myeloid leukaemia by Christopher S. Hourigan, Judith E. Karp

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Molecular foundations of cancer: New targets for intervention

    Molecular foundations of cancer: New targets for intervention by Judith E. Karp, Samuel Broder

    Published 1995
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Lessons from tumor reversion for cancer treatment

    Lessons from tumor reversion for cancer treatment by Robert Amson, Judith E. Karp, Adam Telerman

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia

    Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia by William P. Vaughan, Judith E. Karp, Philip J. Burke

    Published 1980
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Increased incidence of fungemia caused by Candida krusei

    Increased incidence of fungemia caused by Candida krusei by William G. Merz, Judith E. Karp, D. Schron, Rein Saral

    Published 1986
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The Secondary Leukemias: Challenges and Research Directions

    The Secondary Leukemias: Challenges and Research Directions by Malcolm A. Smith, Ronald P. McCaffrey, Judith E. Karp

    Published 1996
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

    Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia by Nestor R. Ramos, Clifton C. Mo, Judith E. Karp, Christopher S. Hourigan

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia

    Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia by Mitch Raponi, R. T. Belly, Judith E. Karp, Jeffrey E. Lancet, David Atkins, Yixin Wang

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA

    Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA by Wenqiang Yu, David Gius, Patrick Onyango, Kristi Muldoon‐Jacobs, Judith E. Karp, Andrew P. Feinberg, Hengmi Cui

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

    Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients by John R. Wingard, William G. Merz, Michael G. Rinaldi, Carole B. Miller, Judith E. Karp, Rein Saral

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

    Increase in<i>Candida krusei</i>Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole by John R. Wingard, William G. Merz, Michael G. Rinaldi, Thomas R. Johnson, Judith E. Karp, Rein Saral

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells

    Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells by Haiming Dai, Husheng Ding, X. Wei Meng, Kevin L. Peterson, Paula A. Schneider, Judith E. Karp, Scott H. Kaufmann

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

    Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse by Scott H. Kaufmann, Judith E. Karp, Phyllis A. Svingen, Stan Krajewski, Philip J. Burke, Steven D. Gore, John C. Reed

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

    Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse by Scott H. Kaufmann, Judith E. Karp, Phyllis A. Svingen, Stan Krajewski, Philip J. Burke, Steven D. Gore, John C. Reed

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors

    MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors by Katherine Knorr, P. Schneider, X. Wei Meng, Haiming Dai, B. Douglas Smith, Allan D. Hess, Judith E. Karp, Scott H. Kaufmann

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy

    Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy by Dionysios Neofytos, Kit Lu, Amy Hatfield-Seung, Amanda L. Blackford, Kieren A. Marr, S. Treadway, Darin Ostrander, Véronique Nussenblatt, Judith E. Karp

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

    A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fluda... by Judith E. Karp, Francis J. Giles, Ivana Gojo, Lawrence E. Morris, Jacqueline M. Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer A. Low

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Epidemiology of Candida kefyr in Patients with Hematologic Malignancies

    Epidemiology of Candida kefyr in Patients with Hematologic Malignancies by Simon F. Dufresne, Kieren A. Marr, Emily Sydnor, Janet F. Staab, Judith E. Karp, Kit Lu, Sean X. Zhang, Christian Lavallée, Trish M. Perl, Dionysios Neofytos

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia

    Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia by Brian Parkin, Harry P. Erba, Peter Ouillette, Diane Roulston, Anjali Purkayastha, Judith E. Karp, Moshe Talpaz, Lisa Kujawski, Sajid Shakhan, Cheng Li, Kerby Shedden, Sami N. Malek

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia

    Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia by Judith E. Karp, B. Douglas Smith, Mark J. Levis, Steven D. Gore, Jacqueline M. Greer, Catherine Hattenburg, Janet Briel, Richard J. Jones, James R. Wright, A.D. Colevas

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: